Dogwood TherapeuticsDWTX
13F holders, Q4 2024 (December 31)10holders
$2.49avg. 13F price*
At the end of Q4 2024, 10 institutions reported holding Dogwood Therapeutics Inc. (DWTX) in their 13F filings. The largest holders were UBS Group AG ($44K), Geode Capital Management, LLC ($27K) and Tower Research Capital LLC (TRC) ($2K).
- Company
- Dogwood Therapeutics Inc.
- CUSIP
- 92829J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
No earlier quarter to compare with.
Ownership 10 holders
| UBS Group AG | 0.00% | Add +137.4% | 17,671 | $44K |
| Geode Capital Management, LLC | 0.00% | Add +18.4% | 10,933 | $27K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +256.1% | 972 | $2K |
| Morgan Stanley | 0.00% | Reduce -1.3% | 600 | $1K |
| Northwestern Mutual Wealth Management Co. | 0.00% | Reduce -50.0% | 381 | $949 |
| Activest Wealth Management | 0.00% | No change | 120 | $299 |
| Group One Trading LLC | 0.00% | Reduce -13.3% | 45 | $112 |
| BlackRock, Inc. | 0.00% | Reduce -0.7% | 30 | $75 |
| Bank of America Corp. | 0.00% | Add +18.5% | 10 | $25 |
| SBI Securities Co., Ltd. | 0.00% | — | 8 | $20 |
"% of holder's portfolio" is DWTX's weight in each manager's 13F, not the share of Dogwood Therapeutics Inc. the manager owns.